Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Apimeds Pharmaceuticals US, Inc. (APUS) vs Bright Green Corporation (BGXXQ)

Apimeds Pharmaceuticals US, Inc. and Bright Green Corporation are both Drug Manufacturers Specialty & Generic companies. Bright Green Corporation is the larger, with a market value of $13.9M against $7.6M — 1.8× the size. Across the 9 metrics below, Bright Green Corporation leads on 7 and Apimeds Pharmaceuticals US, Inc. on 2.

Valuation

Metric APUS BGXXQ Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.14
P/S n/m n/m 2.25
P/B 0.12 n/m 1.90
Price to free cash flow n/m n/m 16.54
EV/EBITDA n/m n/m 12.29
EV/Sales n/m n/m 2.56
Earnings yield (504.41%) 0.00% (2.99%)
Free cash flow yield (107.35%) 0.00% 0.00%

Profitability

Metric APUS BGXXQ Drug Manufacturers Specialty & Generic median
Gross margin — 0.00% 53.94%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (100.13%) (73.60%) (0.40%)
Return on assets (84.20%) (44.80%) (3.32%)
Return on invested capital (15.96%) (39.35%) 0.00%

Growth

Metric APUS BGXXQ Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — — 10.01%
EPS growth (last fiscal year) (205.56%) 58.82% —
Revenue growth, 5-year CAGR — — 6.74%
Net income growth, 5-year CAGR — — 0.00%

Health

Metric APUS BGXXQ Drug Manufacturers Specialty & Generic median
Debt to equity 0.08 0.07 0.05
Current ratio 0.51 0.01 2.31
Net debt to EBITDA 0.38 (0.02) 0.85

Dividend

Metric APUS BGXXQ Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.70%
Payout ratio — — 0.00

Size

Metric APUS BGXXQ Drug Manufacturers Specialty & Generic median
Market cap 7.59m 13.88m 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack